세계 혈장 단백질 치료제 시장 : 제품 유형별, 용도별, 국가별, 지역별- 산업 분석 - 시장 규모, 시장 점유율 및 예측(2024년-2032년)

REPORT HIGHLIGHT

Plasma Protein Therapeutic Market size was valued at USD 30,053 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Plasma protein therapies are exceptional biologic medications that are administered through infusion or injection to address a diverse range of uncommon, life-threatening, chronic, and genetic ailments. These conditions encompass bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, as well as infectious diseases like tetanus, hepatitis, and rabies. The utilization of plasma-derived medicines is crucial for patients suffering from rare diseases that can solely be managed through these therapies. Moreover, these medicines play a vital role in everyday medical practices, emergency and critical care scenarios, and preventive medicine. On a daily basis, approximately 300,000 European patients heavily rely on plasma protein therapies to effectively treat various critical medical conditions. These conditions may include rare genetic diseases, chronic ailments, or life-threatening medical emergencies resulting from accidents and trauma. For these patients, plasma-derived medicines serve as a lifeline by aiding the body in replacing missing or deficient proteins. The absence of consistent access to these treatments would result in the loss of many lives or a significant decline in the quality of life for these individuals.

Plasma Protein Therapeutic Market- Market Dynamics

Increase in autoimmune disorders, immune deficiency disorders, neurological and bleeding disorders are projected to drive the growth of market.

Plasma protein therapeutics, such as plasma-derived immunoglobulins, are utilized in the treatment of specific autoimmune disorders. The rising prevalence of autoimmune diseases contributes to the increasing demand for plasma-based therapies, thereby propelling market expansion. Based on comprehensive research and data collected from countries with robust epidemiological resources, such as the Scandinavian countries, it is estimated that autoimmune diseases collectively affect approximately 3% of the US population, equivalent to around 10 million individuals. To better comprehend this estimation considers the current US population of 329 million. Additionally, the market is expected to witness a surge in the incidence of immune deficiency disorders, neurological disorders, and bleeding disorders, resulting in a larger patient pool necessitating therapeutic interventions. The prevalence of neurological disorders specifically can drive the demand for these therapeutic options. The prevalence rates of various neurological disorders across different regions of the country range from 967 to 4,070 per 100,000 population, with an average of 2,394, indicating that over 30 million people are affected by neurological disorders. Moreover, ongoing advancements in therapeutic technologies, such as the development of recombinant proteins and engineered plasma proteins, present opportunities for innovation within the market. However, it is important to note that the high cost of treatment and the potential risks of contamination and transmission may impede the growth of the market.

Plasma Protein Therapeutic Market- Key Insights

• As per the analysis shared by our research analyst, the global Plasma Protein Therapeutic market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

• Based on product type segmentation, Immunoglobulin was predicted to show maximum market share in the year 2023

• Based on application segmentation, Primary Immunodeficiency Disorder (PIDD) was the leading type in 2023

• On the basis of region, Asia pacific was the leading revenue generator in 2023

Plasma Protein Therapeutic Market- Segmentation Analysis:

The Global Plasma Protein Therapeutic Market is segmented on the basis of Product Type, Application and Region.

The market is divided into three categories based on product type: Albumin, Immunoglobulin, Plasma-derived Factor VIII and Others. The market is largely influenced by the dominance of the Immunoglobulin segment. Immunoglobulin products hold significant importance in the Plasma Protein Therapeutic market as they are vital in treating a range of medical conditions such as immunodeficiency disorders, autoimmune diseases, and neurological disorders.

The market is divided into two categories based on application: Hemophilia, Primary Immunodeficiency Disorder (PIDD), Idiopathic Thrombocytopenic Purpura (ITP) and Others. The market is primarily dominated by the segment of Primary Immunodeficiency Disorder (PIDD). In cases of PIDD, where the immune system is compromised, patients frequently experience a deficiency in antibodies. Immunoglobulin Replacement Therapy, which is derived from human plasma, plays a crucial role in the management of PIDD. This therapy entails the administration of immunoglobulins to bolster the patient's immune response.

Plasma Protein Therapeutic Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by the Asia Pacific region, primarily due to its well-established healthcare infrastructure and the focused efforts of market players in research and development for plasma protein therapeutics. In recent years, Asia Pacific has witnessed significant growth in its healthcare infrastructure, with investments being made in medical facilities, hospitals, and research centers, thereby contributing to the overall improvement of the healthcare ecosystem. Notably, the Chinese government has successfully established a robust healthcare system, which is quite challenging considering the country's status as the largest developing nation in the world. Through continuous efforts of successive governments, the Chinese mainland is projected to have a total of 1,030,935 healthcare institutions by the end of 2021, including 36,570 hospitals and 977,790 primary-level clinics. In terms of market size, Europe holds the second-largest position during the forecast period, driven by the increasing demand for advanced treatment options and the growth of developing economies.

Plasma Protein Therapeutic Market- Competitive Landscape:

In contrast to the conventional pharmaceutical industry, the plasma industry utilizes human blood plasma, a living cell, as its primary material for producing life-saving medications. The production of these medications relies on a limited supply of raw material, which is generally more expensive and complex to obtain compared to non-living molecules and biologics grown in biotechnology facilities. To remain competitive in the market, ongoing research and development efforts are crucial. Companies allocate investments towards the development of new and improved plasma-derived products, the enhancement of manufacturing processes, and the exploration of new therapeutic applications. Biotechnology advancements, such as the creation of recombinant proteins, are areas of focus for many companies as they strive to meet the increasing demand for safer and more sustainable treatment options. Companies with a global presence have an advantage in accessing diverse markets. They establish manufacturing facilities, distribution networks, and partnerships to ensure the availability of their products in various regions. As the demand for plasma-derived therapies continues to rise, companies are likely to persist in investing in research and development, exploring strategic partnerships, and adapting to evolving market dynamics to maintain their competitive edge.

Recent Advancements:

In May 2023, Biotest AG now has 28 nations on its market due to marketing authorizations it was granted to sell Cytotect, a CMV-hyper immunoglobulin, in five more countries: the Czech Republic, Slovakia, Lituania, Ireland, and Romania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• CSL
• Grifols, S.A.
• Takeda
• Octapharma AG
• Biotest AG
• Kedrion S.p.A

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Albumin
• Immunoglobulin
• Plasma-derived Factor VIII
• Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Hemophilia
• Primary Immunodeficiency Disorder (PIDD)
• Idiopathic Thrombocytopenic Purpura (ITP)
• Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Plasma Protein Therapeutic Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Plasma Protein Therapeutic Market Snippet by Product Type
  • 2.1.2. Plasma Protein Therapeutic Market Snippet by Application
  • 2.1.3. Plasma Protein Therapeutic Market Snippet by Country
  • 2.1.4. Plasma Protein Therapeutic Market Snippet by Region
• 2.2. Competitive Insights

3. Plasma Protein Therapeutic Key Market Trends

• 3.1. Plasma Protein Therapeutic Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Plasma Protein Therapeutic Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Plasma Protein Therapeutic Market Opportunities
• 3.4. Plasma Protein Therapeutic Market Future Trends

4. Plasma Protein Therapeutic Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Plasma Protein Therapeutic Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Plasma Protein Therapeutic Market Landscape

• 6.1. Plasma Protein Therapeutic Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Plasma Protein Therapeutic Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
  • 7.1.2. Albumin
  • 7.1.3. Immunoglobulin
  • 7.1.4. Plasma-derived Factor VIII
  • 7.1.5. Others

8. Plasma Protein Therapeutic Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. Hemophilia
  • 8.1.3. Primary Immunodeficiency Disorder (PIDD)
  • 8.1.4. Idiopathic Thrombocytopenic Purpura (ITP)
  • 8.1.5. Others

9. Plasma Protein Therapeutic Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Plasma Protein Therapeutic Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Plasma Protein Therapeutic Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Plasma Protein Therapeutic Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Plasma Protein Therapeutic Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Plasma Protein Therapeutic Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Plasma Protein Therapeutic Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. CSL
  • 10.2.2. Grifols, S.A.
  • 10.2.3. Takeda
  • 10.2.4. Octapharma AG
  • 10.2.5. Biotest AG
  • 10.2.6. Kedrion S.p.A

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us